Compare BIO-TECHNE Corp (TECH) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs ProShares UltraPro QQQ ETF — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while ProShares UltraPro QQQ ETF trades at $82.44 (market cap $40.39B). The key difference: ProShares UltraPro QQQ ETF is far larger — about 3.6× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while ProShares UltraPro QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and ProShares UltraPro QQQ ETF for 24 Days on average.
| TECH | TQQQ | |
|---|---|---|
Market Cap | $11.37B | $40.39B |
Volume | 3,153,511 | 37,786,708 |
Sector | Health | Leveraged / Inverse |
52-Week High | $72.61 | $87.22 |
52-Week Low | $43.31 | $37.89 |
Typical Hold Time | 63 Days | 24 Days |
Enterprise Value | $11.40B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
TQQQ, a 3x leveraged ETF tracking the Nasdaq-100, trades at $83.6, down 0.77% on the day. Technical indicators show a bullish trend with moving averages supporting upside momentum, though oscillators are neutral and RSI levels suggest potential overbought conditions. Recent news highlights concerns over hidden costs and volatility decay, while institutional activity shows mixed positioning. The fund's performance remains tied to the tech-heavy index, with AI-driven earnings from components being a key catalyst.
The outlook for TQQQ is cautiously optimistic, driven by strong tech sector earnings and bullish technical trends, but risks include amplified losses during market downturns, high expense ratios, and volatility decay. Investors should weigh the leveraged structure's benefits against potential drawdowns, with attention to upcoming tech earnings and broader market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
